Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Efficacy of Oral Leukotriene in long term therapy of mild and moderate obstructive sleep apnea syndrome (OSAS) in children.

Trial Profile

Efficacy of Oral Leukotriene in long term therapy of mild and moderate obstructive sleep apnea syndrome (OSAS) in children.

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 22 Feb 2013

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Montelukast (Primary) ; Budesonide
  • Indications Sleep apnoea syndrome
  • Focus Therapeutic Use
  • Acronyms SB-OSAS

Most Recent Events

  • 14 Feb 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
  • 24 Mar 2012 Actual initiation date changed from 1 Jan 2009 to 3 Jun 2008 as reported by European Clinical Trials Database.
  • 27 Aug 2011 New trial record

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top